IT1229075B
(it)
*
|
1985-04-05 |
1991-07-17 |
Fidia Farmaceutici |
Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
|
US5166331A
(en)
*
|
1983-10-10 |
1992-11-24 |
Fidia, S.P.A. |
Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
|
CA1295238C
(en)
*
|
1986-04-04 |
1992-02-04 |
David R. Gibson |
Methods and materials for use in corneal wounds
|
US5541166A
(en)
*
|
1987-01-23 |
1996-07-30 |
The Australian National University |
Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity
|
IL85145A
(en)
*
|
1987-01-23 |
1994-08-26 |
Univ Australian |
Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity
|
US5145841A
(en)
*
|
1987-03-19 |
1992-09-08 |
Arthropharm Pty. Limited |
Anti-inflammatory compounds and compositions
|
US5668116A
(en)
*
|
1987-03-19 |
1997-09-16 |
Anthropharm Pty. Limited |
Anti-inflammatory compounds and compositions
|
DK505488D0
(da)
*
|
1987-12-21 |
1988-09-09 |
Bar Shalom Daniel |
Middel og anvendelse af samme
|
US5916880A
(en)
*
|
1987-12-21 |
1999-06-29 |
Bukh Meditec A/S |
Reduction of skin wrinkling using sulphated sugars
|
US5510329A
(en)
*
|
1988-04-26 |
1996-04-23 |
Ramot University For Applied Research And Industrial Development Ltd. |
Preparations for the treatment of eyes
|
JP2671381B2
(ja)
*
|
1988-05-23 |
1997-10-29 |
藤沢薬品工業株式会社 |
点眼剤
|
US6271216B1
(en)
|
1989-07-24 |
2001-08-07 |
Allergan |
Stable solution of hyaluronate in a balanced salt medium
|
CA1340994C
(en)
*
|
1989-09-21 |
2000-05-16 |
Rudolf Edgar Dr. Falk |
Treatment of conditions and disease
|
US5627162A
(en)
*
|
1990-01-11 |
1997-05-06 |
Gwon; Arlene E. |
Methods and means for control of proliferation of remnant cells following surgery
|
US5824658A
(en)
*
|
1990-09-18 |
1998-10-20 |
Hyal Pharmaceutical Corporation |
Topical composition containing hyaluronic acid and NSAIDS
|
US5990096A
(en)
*
|
1990-09-18 |
1999-11-23 |
Hyal Pharmaceutical Corporation |
Formulations containing hyaluronic acid
|
CA2061703C
(en)
*
|
1992-02-20 |
2002-07-02 |
Rudolf E. Falk |
Formulations containing hyaluronic acid
|
US5910489A
(en)
*
|
1990-09-18 |
1999-06-08 |
Hyal Pharmaceutical Corporation |
Topical composition containing hyaluronic acid and NSAIDS
|
US5639738A
(en)
*
|
1992-02-20 |
1997-06-17 |
Hyal Pharmaceutical Corporation |
Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
|
KR940011725B1
(ko)
*
|
1990-11-28 |
1994-12-23 |
가부시키가이샤 도시바 |
회전양극형 x선관의 제조방법 및 제조장치
|
US5492936A
(en)
*
|
1990-11-30 |
1996-02-20 |
Allergan, Inc. |
Bimodal molecular weight hyaluronate formulations and methods for using same
|
US5977088A
(en)
*
|
1991-07-03 |
1999-11-02 |
Hyal Pharmaceutical Corporation |
Formulations containing hyaluronic acid
|
US5792753A
(en)
*
|
1991-07-03 |
1998-08-11 |
Hyal Pharmaceutical Corporation |
Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
|
US6022866A
(en)
*
|
1991-07-03 |
2000-02-08 |
Hyal Pharmaceutical Corporation |
Use of hyaluronic acid and forms to prevent arterial restenosis
|
US6103704A
(en)
*
|
1991-07-03 |
2000-08-15 |
Hyal Pharmaceutical Corporation |
Therapeutic methods using hyaluronic acid
|
US5817644A
(en)
*
|
1991-07-03 |
1998-10-06 |
Hyal Pharmaceutical Corporation |
Targeting of dosages of medicine and therapeutic agents
|
US5990095A
(en)
*
|
1991-07-03 |
1999-11-23 |
Hyal Pharmaceutical Corporation |
Use of hyaluronic acid and forms to prevent arterial restenosis
|
WO1994007505A1
(en)
*
|
1991-07-03 |
1994-04-14 |
Norpharmco Inc. |
Use of hyaluronic acid and forms to prevent arterial restenosis
|
CA2061567C
(en)
*
|
1992-02-20 |
1998-02-03 |
Rudolf E. Falk |
Use of hyaluronic acid to repair ischemia reperfusion damage
|
US5942498A
(en)
*
|
1992-02-20 |
1999-08-24 |
Hyal Pharmaceutical Corporation |
Formulations containing hyaluronic acid
|
US6218373B1
(en)
|
1992-02-20 |
2001-04-17 |
Hyal Pharmaceutical Corporation |
Formulations containing hyaluronic acid
|
US6114314A
(en)
*
|
1992-02-21 |
2000-09-05 |
Hyal Pharmaceutical Corp. |
Formulations containing hyaluronic acid
|
US5767106A
(en)
*
|
1992-02-21 |
1998-06-16 |
Hyal Pharmaceutical Corporation |
Treatment of disease and conditions associated with macrophage infiltration
|
US5273056A
(en)
*
|
1992-06-12 |
1993-12-28 |
Alcon Laboratories, Inc. |
Use of combinations of viscoelastics during surgery
|
US6083933A
(en)
*
|
1999-04-19 |
2000-07-04 |
Stellar International Inc. |
Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
|
US7363928B2
(en)
|
2001-12-21 |
2008-04-29 |
Alcon, Inc. |
Dilution resistant viscoelastic compositions
|
AU2002360752A1
(en)
*
|
2001-12-21 |
2003-07-30 |
Alcon, Inc. |
Viscoelastics for ocular surgery
|
US20040118414A1
(en)
|
2002-12-20 |
2004-06-24 |
Shah Mandar V |
Surface modified viscoelastics for ocular surgery
|
US7820194B2
(en)
*
|
2001-12-21 |
2010-10-26 |
Alcon, Inc. |
Combinations of viscoelastics for use during surgery
|
US20040161476A1
(en)
|
2003-02-19 |
2004-08-19 |
Hahn Sungtack Samuel |
Cystitis treatment with high dose chondroitin sulfate
|
EP1896053B1
(de)
|
2004-07-06 |
2018-10-31 |
ZymoGenetics, Inc. |
Pharmazeutische zusammensetzung enthaltend fgf-18 und einen il-1 antagonisten sowie verfahren zur verwendung derselben
|
WO2006035969A1
(ja)
|
2004-09-28 |
2006-04-06 |
Senju Pharmaceutical Co., Ltd. |
キサンタンガムおよびアミノ酸を含有する眼科用組成物
|
WO2007008206A1
(en)
*
|
2005-07-11 |
2007-01-18 |
Alcon, Inc. |
Dilution resistant viscoelastic compositions
|
ITMI20061030A1
(it)
|
2006-05-26 |
2007-11-27 |
Altergon Sa |
Nuova composizione comprendente glicosamminoglicani a viscosita' controllata e uso di tale composizione nella terapuia della cistite cronica
|
ES2621876T3
(es)
|
2006-09-13 |
2017-07-05 |
Enhance Skin Products Inc. |
Composición cosmética para el tratamiento de la piel y procedimientos de la misma
|
DE102006049580A1
(de)
*
|
2006-10-20 |
2008-04-24 |
Rochel, Michael, Dr. med. |
Topische Zusammensetzung zur Behandlung von Ekzemen
|
ES2405314T3
(es)
|
2008-05-13 |
2013-05-30 |
Apharm S.R.L. |
Composiciones y uso oral de glicosaminoglicanos
|
PT2435021E
(pt)
|
2009-05-25 |
2013-09-30 |
Sofar Swiss Sa |
Utilização de uma combinação fixa de glicosaminoglicano e composição mastigável compreendendo a referida combinação fixa
|
EP2596796B1
(de)
|
2011-11-24 |
2013-11-13 |
Quimera Ingenieria Biomedica, S.L. |
Komplex erhalten aus Hyaluronsäure oder deren Salzen und Chondroitin-Sulfatmischungen
|
EP2886104A1
(de)
*
|
2013-12-11 |
2015-06-24 |
Patir, Suleyman |
Intraartikuläres Gel
|
CZ33324U1
(cs)
|
2019-09-06 |
2019-10-25 |
Contipro A.S. |
Hydrogel na bázi zesíťovaného hydroxyfenylového derivátu kyseliny hyaluronové
|
US12102632B2
(en)
*
|
2020-08-26 |
2024-10-01 |
Somerset Therapeutics, Llc |
Quinolone dispersions
|
US12016855B2
(en)
|
2020-08-26 |
2024-06-25 |
Somerset Therapeutics, Llc |
Prednisolone and moxifloxacin compositions and methods
|